Background: Approximately 2% of the human core promoter short tandem repeats (STRs) reach lengths of ≥6 repeats, which may in part be a result of adaptive evolutionary processes and natural selection. A single-exon transcript of the human nescient helix loop helix 2 (NHLH2) gene is flanked by the longest CA-repeat detected in a human protein-coding gene core promoter (Ensembl transcript ID: ENST00000369506.1). NHLH2 is involved in several biological and pathological pathways, such as motivated exercise, obesity, and diabetes. Methods: The allele and genotype distribution of the NHLH2 CA-repeat were investigated by sequencing in 655 Iranian subjects, consisting of late-onset neurocognitive disorder (NCD) as a clinical entity (n = 290) and matched controls (n = 365). The evolutionary trend of the CA-repeat was also studied across vertebrates. Results: The allele range was between 9 and 25 repeats in the NCD cases, and 12 and 24 repeats in the controls. At the frequency of 0.56, the 21-repeat allele was the predominant allele in the controls. While the 21-repeat was also the predominant allele in the NCD patients, we detected significant decline of the frequency (p < 0.0001) and homozygosity (p < 0.006) of this allele in this group. Furthermore, 12 genotypes were detected across 16 patients (5.5% of the entire NCD sample) and not in the controls (disease-only genotypes; p < 0.0003), consisting of at least one extreme allele. The extreme alleles were at 9, 12, 13, 18, and 19 repeats (extreme short end), and 23, 24, and 25 repeats (extreme long end), and their frequencies ranged between 0.001 and 0.04. The frequency of the 21-repeat allele significantly dropped to 0.09 in the disease-only genotype compartment (p < 0.0001). Evolutionarily, while the maximum length of the NHLH2 CA-repeat was 11 repeats in non-primates, this CA-repeat was ≥14 repeats in primates and reached maximum length in human. Conclusion: We propose a novel locus for late-onset NCD at the NHLH2 core promoter exceptionally long CA-STR and natural selection at this locus. Furthermore, there was indication of genotypes at this locus that unambiguously linked to late-onset NCD. This is the first instance of natural selection in favor of a predominantly abundant STR allele in human and its differential distribution in late-onset NCD.

1.
Mohammadparast
S
,
Bayat
H
,
Biglarian
A
,
Ohadi
M
.
Exceptional expansion and conservation of a CT-repeat complex in the core promoter of PAXBP1 in primates
.
Am J Primatol
.
2014
Aug
;
76
(
8
):
747
56
.
[PubMed]
0275-2565
2.
Press
MO
,
Hall
AN
,
Morton
EA
,
Queitsch
C
.
Substitutions Are Boring: Some Arguments about Parallel Mutations and High Mutation Rates
.
Trends Genet
.
2019
Apr
;
35
(
4
):
253
64
.
[PubMed]
0168-9525
3.
Ohadi
M
,
Mohammadparast
S
,
Darvish
H
.
Evolutionary trend of exceptionally long human core promoter short tandem repeats
.
Gene
.
2012
Oct
;
507
(
1
):
61
7
.
[PubMed]
0378-1119
4.
Bushehri
A
,
Barez
MR
,
Mansouri
SK
,
Biglarian
A
,
Ohadi
M
.
Genome-wide identification of human- and primate-specific core promoter short tandem repeats
.
Gene
.
2016
Aug
;
587
(
1
):
83
90
.
[PubMed]
0378-1119
5.
Emamalizadeh
B
,
Jamshidi
J
,
Movafagh
A
,
Ohadi
M
,
Khaniani
MS
,
Kazeminasab
S
, et al.
RIT2 polymorphisms: is there a differential association?
Mol Neurobiol
.
2017
Apr
;
54
(
3
):
2234
40
.
[PubMed]
0893-7648
6.
Khademi
E
,
Alehabib
E
,
Shandiz
EE
,
Ahmadifard
A
,
Andarva
M
,
Jamshidi
J
, et al.
Support for “Disease-Only” Genotypes and Excess of Homozygosity at the CYTH4 Primate-Specific GTTT-Repeat in Schizophrenia
.
Genet Test Mol Biomarkers
.
2017
Aug
;
21
(
8
):
485
90
.
[PubMed]
1945-0265
7.
Alizadeh
F
,
Moharrami
T
,
Mousavi
N
,
Yazarlou
F
,
Bozorgmehr
A
,
Shahsavand
E
, et al.
Disease-only alleles at the extreme ends of the human ZMYM3 exceptionally long 5′ UTR short tandem repeat in bipolar disorder: A pilot study
.
J Affect Disord
.
2019
May
;
251
:
86
90
.
[PubMed]
0165-0327
8.
Nikkhah
M
,
Rezazadeh
M
,
Khorram Khorshid
HR
,
Biglarian
A
,
Ohadi
M
.
An exceptionally long CA-repeat in the core promoter of SCGB2B2 links with the evolution of apes and Old World monkeys
.
Gene
.
2016
Jan
;
576
(
1 Pt 1
):
109
14
.
[PubMed]
0378-1119
9.
Wankhade
UD
,
Vella
KR
,
Fox
DL
,
Good
DJ
.
Deletion of Nhlh2 results in a defective torpor response and reduced Beta adrenergic receptor expression in adipose tissue
.
PLoS One
.
2010
Aug
;
5
(
8
):
e12324
.
[PubMed]
1932-6203
10.
Good
DJ
,
Braun
T
.
NHLH2: at the intersection of obesity and fertility
.
Trends Endocrinol Metab
.
2013
Aug
;
24
(
8
):
385
90
.
[PubMed]
1043-2760
11.
Good
DJ
,
Li
M
,
Deater-Deckard
K
.
A genetic basis for motivated exercise
.
Exerc Sport Sci Rev
.
2015
Oct
;
43
(
4
):
231
7
.
[PubMed]
0091-6331
12.
Paillard
T
.
Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement
.
Sports Med Open
.
2015
;
1
(
1
):
20
.
[PubMed]
2199-1170
13.
Pedditzi
E
,
Peters
R
,
Beckett
N
.
The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies
.
Age Ageing
.
2016
Jan
;
45
(
1
):
14
21
.
[PubMed]
0002-0729
14.
Sherzai
D
,
Sherzai
A
,
Lui
K
,
Pan
D
,
Chiou
D
,
Bazargan
M
, et al.
The Association Between Diabetes and Dementia Among Elderly Individuals: A Nationwide Inpatient Sample Analysis
.
J Geriatr Psychiatry Neurol
.
2016
May
;
29
(
3
):
120
5
.
[PubMed]
0891-9887
15.
Gallaway
PJ
,
Miyake
H
,
Buchowski
MS
,
Shimada
M
,
Yoshitake
Y
,
Kim
AS
, et al.
Physical activity: a viable way to reduce the risks of mild cognitive impairment, Alzheimer’s disease, and vascular dementia in older adults
.
Brain Sci
.
2017
Feb
;
7
(
2
):
22
.
[PubMed]
2076-3425
16.
King
E
,
O’Brien
JT
,
Donaghy
P
,
Morris
C
,
Barnett
N
,
Olsen
K
, et al.
Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
.
J Neurol Neurosurg Psychiatry
.
2018
Apr
;
89
(
4
):
339
45
.
[PubMed]
0022-3050
17.
Hodkinson
HM
.
Evaluation of a mental test score for assessment of mental impairment in the elderly
.
Age Ageing
.
1972
Nov
;
1
(
4
):
233
8
.
[PubMed]
0002-0729
18.
Foroughan
M
,
Wahlund
LO
,
Jafari
Z
,
Rahgozar
M
,
Farahani
IG
,
Rashedi
V
.
Validity and reliability of Abbreviated Mental Test Score (AMTS) among older Iranian
.
Psychogeriatrics
.
2017
Nov
;
17
(
6
):
460
5
.
[PubMed]
1346-3500
19.
Carpenter CR, Banerjee J, Keyes D, Eagles D, Schnitker L, Barbic D, et al. Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis. Acad Emerg Med. 2019 Feb;26(2):226–45.
20.
Goodsell
DS
,
Dickerson
RE
.
Bending and curvature calculations in B-DNA
.
Nucleic Acids Res
.
1994
Dec
;
22
(
24
):
5497
503
.
[PubMed]
0305-1048
21.
Soetaert
K.
plot3D: Tools for plotting 3-D and 2-D data. R package version.
2014
:10-2.
22.
Karantzoulis
S
,
Galvin
JE
.
Distinguishing Alzheimer’s disease from other major forms of dementia
.
Expert Rev Neurother
.
2011
Nov
;
11
(
11
):
1579
91
.
[PubMed]
1473-7175
23.
Cunningham
EL
,
McGuinness
B
,
Herron
B
,
Passmore
AP
.
Dementia
.
Ulster Med J
.
2015
May
;
84
(
2
):
79
87
.
[PubMed]
2046-4207
24.
Lin
YF
,
Smith
AV
,
Aspelund
T
,
Betensky
RA
,
Smoller
JW
,
Gudnason
V
, et al.
Genetic overlap between vascular pathologies and Alzheimer’s dementia and potential causal mechanisms
.
Alzheimers Dement
.
2019
Jan
;
15
(
1
):
65
75
.
[PubMed]
1552-5260
25.
Dickson
DW
,
Heckman
MG
,
Murray
ME
,
Soto
AI
,
Walton
RL
,
Diehl
NN
, et al.
APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology
.
Neurology
.
2018
Sep
;
91
(
12
):
e1182
95
.
[PubMed]
0028-3878
26.
Patel
D
,
Mez
J
,
Vardarajan
BN
,
Staley
L
,
Chung
J
,
Zhang
X
, et al.;
Alzheimer’s Disease Sequencing Project
.
Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry
.
JAMA Netw Open
.
2019
Mar
;
2
(
3
):
e191350
.
[PubMed]
2574-3805
27.
Smith
PJ
,
Mabe
S
,
Sherwood
A
,
Babyak
MA
,
Doraiswamy
PM
,
Welsh-Bohmer
KA
, et al.
Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment
.
J Alzheimers Dis
.
2019
;
71
(
3
):
921
9
.
[PubMed]
1387-2877
28.
Drenos
F
,
Kirkwood
TB
,
Sherwood
A
,
Babyak
MA
,
Doraiswamy
PM
,
Welsh-Bohmer
KA
, et al.
Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E
.
PLoS One
.
2010
Apr
;
5
(
4
):
e10022
.
[PubMed]
1932-6203
29.
Raj
T
,
Shulman
JM
,
Keenan
BT
,
Chibnik
LB
,
Evans
DA
,
Bennett
DA
, et al.
Alzheimer disease susceptibility loci: evidence for a protein network under natural selection
.
Am J Hum Genet
.
2012
Apr
;
90
(
4
):
720
6
.
[PubMed]
0002-9297
30.
Watts
PC
,
Kallio
ER
,
Koskela
E
,
Lonn
E
,
Mappes
T
,
Mokkonen
M
. Stabilizing selection on microsatellite allele length at arginine vasopressin 1a receptor and oxytocin receptor loci. Proceedings Biological sciences. 2017 Dec 20;284(
1869
).
31.
Sala
E
,
Filopanti
M
,
Ferrante
E
,
Barbieri
AM
,
Malchiodi
E
,
Verrua
E
, et al.
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly
.
Eur J Clin Invest
.
2014
Dec
;
44
(
12
):
1222
9
.
[PubMed]
0014-2972
32.
Fotsing
SF
,
Margoliash
J
,
Wang
C
,
Saini
S
,
Yanicky
R
,
Shleizer-Burko
S
, et al.
The impact of short tandem repeat variation on gene expression
.
Nat Genet
.
2019
Nov
;
51
(
11
):
1652
9
.
[PubMed]
1061-4036
33.
Morrison
CD
.
Leptin signaling in brain: a link between nutrition and cognition?
Biochimica et biophysica acta (BBA)-molecular basis of disease.
2009
;1792(5):401-08.
34.
Albala
C
,
Angel
B
,
Lera
L
,
Sanchez
H
,
Marquez
C
,
Fuentes
P
.
Low leptin availability as a risk factor for dementia in Chilean older people
.
Dement Geriatr Cogn Disord Extra
.
2016
Jul
;
6
(
2
):
295
302
.
[PubMed]
1664-5464
35.
Marwarha
G
,
Ghribi
O
.
Leptin signaling and Alzheimer’s disease
.
Am J Neurodegener Dis
.
2012
;
1
(
3
):
245
65
.
[PubMed]
2165-591X
36.
Lloret
A
,
Monllor
P
,
Esteve
D
,
Cervera-Ferri
A
,
Lloret
MA
.
Obesity as a risk factor for Alzheimer’s disease: implication of leptin and glutamate
.
Front Neurosci
.
2019
May
;
13
:
508
.
[PubMed]
1662-4548
37.
Peretti
D
,
Bastide
A
,
Radford
H
,
Verity
N
,
Molloy
C
,
Martin
MG
, et al.
RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration
.
Nature
.
2015
Feb
;
518
(
7538
):
236
9
.
[PubMed]
0028-0836
38.
Good
DJ
,
Zhang
H
,
Grange
RW
,
Braun
T
.
POMC Neurons and the Transcriptional Regulation of Motivated Exercise
.
Exerc Sport Sci Rev
.
2020
Jan
;
48
(
2
):
74
82
.
[PubMed]
0091-6331
39.
Choo
T
,
Barak
Y
,
East
A
.
The Effects of Intuitive Movement Reembodiment on the Quality of Life of Older Adults With Dementia: A Pilot Study
.
Am J Alzheimers Dis Other Demen
.
2020
Jan-Dec
;
35
:
1533317519860331
.
[PubMed]
1533-3175
40.
Darvish
H
,
Heidari
A
,
Hosseinkhani
S
,
Movafagh
A
,
Khaligh
A
,
Jamshidi
J
, et al.
Biased homozygous haplotypes across the human caveolin 1 upstream purine complex in Parkinson's disease.
Journal of molecular neuroscience : MN.
2013
Oct
;51(2):389-93.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.